B. Pressnail

Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphoma

A. LaCasce, J. Friedberg, J. Leonard, 2017, British journal of haematology.

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

M. Gleave, J. Nemunaitis, G. Nicholas, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Improving Access to Radiotherapy Services in the Simcoe-Muskoka Region of Ontario: Needs Assessment Study

Liying Zhang, C. Danjoux, E. Szumacher, 2007 .

Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma

P. Davey, R. Aviv, P. Goh, 2009, Current oncology.

Synchronous dual hematological malignancies: new or underreported entity?

R. Kotchetkov, J. Mclean, E. Ellison, 2018, Hematology.

Phase I/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer

M. Gleave, J. Nemunaitis, G. Nicholas, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.